Gregory Merril

About Gregory Merril

Gregory Merril is a director at BiomX.

Form D filings name Gregory Merril as a chief executive officer and director at Adaptive Phage Therapeutics.

Gregory Merril reports to the SEC as a director of 1 public company.

Gregory Merril first appears on SEC filings in 2017.

Experience

This experience comes from SEC filings. The years are when the filings name Gregory Merril in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Gregory Merril works with at each company, as listed on that company's latest Form D.

Sources

1. SECAdaptive Phage Therapeutics, Inc. Form D, filed Jun 9, 2023
2. SECForms 3, 4 and 5 filed by Gregory Merril (SEC filer 2015934)